[DEBUG-WINDOW 처리영역 보기]
즐겨찾기  |  뉴스레터  |  오늘의 정보 회원가입   로그인
BRIC홈 한국을 빛내는 사람들
버그알림
스폰서배너광고 안내  배너1 배너2 배너3
전체보기 추천논문 상위피인용 인터뷰 그이후 한빛사통계
김선희
김선희 (Sun Hee Kim) 저자 이메일 보기
한국기초과학지원연구원, 이화여자대학교
조회 629  인쇄하기 주소복사 트위터 공유 페이스북 공유 
Mechanistic Insights into Tunable Metal-Mediated Hydrolysis of Amyloid-β Peptides

Jeffrey S. Derrick, Jiwan Lee, Shin Jung C. Lee, Yujeong Kim§∥, Eunju Nam, Hyeonwoo Tak, Juhye Kang, Misun Lee, Sun Hee Kim*§∥, Kiyoung Park*‡, Jaeheung Cho*⊥, and Mi Hee Lim*† 

Department of Chemistry, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Republic of Korea
Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea
§ Western Seoul Center, Korea Basic Science Institute (KBSI), Seoul 03759, Republic of Korea
Department of Chemistry and Nano Science, Ewha Womans University, Seoul 03760, Republic of Korea
Department of Emerging Materials Science, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu 42988, Republic of Korea

*Corresponding authors

Abstract
An amyloidogenic peptide, amyloid-β (Aβ), has been implicated as a contributor to the neurotoxicity of Alzheimer’s disease (AD) that continues to present a major socioeconomic burden for our society. Recently, the use of metal complexes capable of cleaving peptides has arisen as an efficient tactic for amyloid management; unfortunately, little has been reported to pursue this strategy. Herein, we report a novel approach to validate the hydrolytic cleavage of divalent metal complexes toward two major isoforms of Aβ (Aβ>40 and Aβ42) and tune their proteolytic activity based on the choice of metal centers (M = Co, Ni, Cu, and Zn) which could be correlated to their anti-amyloidogenic properties. Such metal-dependent tunability was facilitated employing a tetra-N-methylated cyclam (TMC) ligand that imparts unique geometric and stereochemical control, which has not been available in previous systems. Co(II)(TMC) was identified to noticeably cleave Aβ peptides and control their aggregation, reporting the first Co(II) complex for such reactivities to the best of our knowledge. Through detailed mechanistic investigations by biochemical, spectroscopic, mass spectrometric, and computational studies, the critical importance of the coordination environment and acidity of the aqua-bound complexes in promoting amide hydrolysis was verified. The biological applicability of Co(II)(TMC) was also illustrated via its potential blood-brain barrier permeability, relatively low cytotoxicity, regulatory capability against toxicity induced by both Aβ>40 and Aβ42 in living cells, proteolytic activity with Aβ peptides under biologically relevant conditions, and inertness toward cleavage of structured proteins. Overall, our approaches and findings on reactivities of divalent metal complexes toward Aβ, along with the mechanistic insights, demonstrate the feasibility of utilizing such metal complexes for amyloid control.

논문정보
TOP5
2017년 선정
- 형식: Research article
- 게재일: 2017년 01월 (BRIC 등록일 2017-01-23)
- 연구진: 국내연구진태극기
관련 보도자료
치매 단백질, 가위처럼 자르는 금속 착물 개발
치매로 잘 알려진 알츠하이머병의 원인을 가위처럼 자르는 물질이 개발됐다. 금속이 가운데 들어간 독특한 구조의 이 물질은 실제 치료제로 활용될 가능성도 높다.임미희 자연과학부 임미희 교수팀은 알츠하이머병의 원인으로 지목되는 아밀로이드-...
'치매 치료의 진전'…UNIST, 치매 단백질 약화 물질 개발
알츠하이머병(치매)의 원인인 '아밀로이드-베타'라는 독성을 가진 단백질을 수분과 만나게 해 약화시키는 금속 착물(원자 하나를 중심으로 다른 원자 등이 붙은 물질)을 개발했다.
  댓글 0
등록
 
목록
엘앤씨바이오
관련링크
김선희 님 전체논문보기 >
관련인물
Jeffrey S. Derrick (UNIST)
김동훈 (한국기초과학지원연구원)
박기영 (Stanford University)
임미희 (한국과학기술원 (KAIST))
조재흥 (대구경북과학기술원)
외부링크
Google (by Sun Hee Kim)
Pubmed (by Sun Hee Kim)
프리미엄 Bio일정 Bio일정 프리미엄 안내
2018 Ajou Biomedical International Symposium / Genoproteomic Signature of Human Diseases
2018 Ajou Biomedical International Symposium / Genoproteomic Signature of Human Diseases
날짜: 2018.11.26
장소: 아주대학교의료원 별관 대강당 (수원)
Human Genome Meeting 2019
Human Genome Meeting 2019
초록접수: ~2018.12.31
사전접수: ~2018.12.31
날짜: 2019.04.24~26
장소: 이화여자대학교 삼성홀
International Forum on Medical Innovation of Cell & Bio Therapy
International Forum on Medical Innovation of Cell & Bio Therapy
사전접수: ~2018.11.21
날짜: 2018.11.23
장소: 서울대학교병원 의생명연구원 1층 강당(대학로 소재)
위로가기
한빛사 홈  |  한빛사FAQ  |  한빛사 문의 및 제안
 |  BRIC소개  |  이용안내  |  이용약관  |  개인정보처리방침  |  이메일무단수집거부
Copyright © BRIC. All rights reserved.  |  문의 member@ibric.org
트위터 트위터    페이스북 페이스북    RSS서비스 RSS